Biglycan Inhibits Capsaicin-Induced Substance P Release by Cultured Dorsal Root Ganglion Neurons.
Peng Shi, Er-Yun Chen, Gabriella Cs-Szabo and 7 others
PMID 26945213WHAT IT FOUND
Biglycan reduced substance P release by 29% in cultured rabbit nerve cells exposed to capsaicin.
This suggests biglycan may modulate pain signaling in vitro, but it provides no evidence that injecting biglycan relieves back pain in humans.
Key findings
01Preincubation with biglycan resulted in a 29% decrease in substance P released by dorsal root ganglion cells compared to capsaicin stimulation alone.
02Capsaicin stimulated substance P release in a dose-dependent manner, with 500 μM capsaicin causing a 13.7-fold increase compared to controls.
03The culture system contained both primary sensory neurons and astrocytes, confirming its validity for studying pain generation mechanisms.
STILL TO COME
How it was doneWhat they foundWhat it means for PTsWhat it means for OTsWhat it means for SLPs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
This is an in vitro study using rabbit cells, not human patients. The findings may not apply to human physiology. The study measured substance P release in a petri dish, not pain perception or clinical outcomes in a living organism. There is no evidence that injecting biglycan or increasing its levels in a human disc would reduce pain. The mechanism by which biglycan interacts with capsaicin is not fully understood and remains speculative.
The easy way to misread this
Do not interpret this as evidence that biglycan injections treat discogenic back pain. The study only showed that biglycan reduced a pain marker in cultured rabbit cells, which is far from proving clinical efficacy in humans.